Legal & General Group’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $23.2M | Buy |
102,433
+5,523
| +6% | +$984K | ﹤0.01% | 813 |
|
|
2026
Q1 | $16.7M | Sell |
96,910
-9,520
| -9% | -$1.77M | ﹤0.01% | 899 |
|
|
2025
Q4 | $21.2M | Sell |
106,430
-1,815
| -2% | -$329K | ﹤0.01% | 825 |
|
|
2025
Q3 | $16.9M | Buy |
108,245
+2,044
| +2% | +$325K | ﹤0.01% | 939 |
|
|
2025
Q2 | $16.1M | Buy |
106,201
+11,614
| +12% | +$1.55M | ﹤0.01% | 945 |
|
|
2025
Q1 | $14.2M | Sell |
94,587
-143,292
| -60% | -$24M | ﹤0.01% | 952 |
|
|
2024
Q4 | $43.9M | Sell |
237,879
-12,485
| -5% | -$2.4M | 0.01% | 639 |
|
|
2024
Q3 | $49.3M | Buy |
250,364
+6,727
| +3% | +$1.4M | 0.01% | 639 |
|
|
2024
Q2 | $50.3M | Sell |
243,637
-11,593
| -5% | -$2.63M | 0.01% | 621 |
|
|
2024
Q1 | $69.2M | Sell |
255,230
-6,610
| -3% | -$1.58M | 0.02% | 559 |
|
|
2023
Q4 | $61.9M | Sell |
261,840
-29,402
| -10% | -$5.78M | 0.02% | 586 |
|
|
2023
Q3 | $57.1M | Sell |
291,242
-13,024
| -4% | -$2.67M | 0.02% | 589 |
|
|
2023
Q2 | $64M | Sell |
304,266
-2,441
| -0.8% | -$486K | 0.02% | 576 |
|
|
2023
Q1 | $61.9M | Buy |
306,707
+5,580
| +2% | +$1.26M | 0.02% | 578 |
|
|
2022
Q4 | $65.6M | Sell |
301,127
-12,862
| -4% | -$2.81M | 0.03% | 560 |
|
|
2022
Q3 | $61.8M | Sell |
313,989
-3,106
| -1% | -$671K | 0.02% | 575 |
|
|
2022
Q2 | $67.8M | Buy |
317,095
+3,098
| +1% | +$757K | 0.02% | 582 |
|
|
2022
Q1 | $89.2M | Buy |
313,997
+11,273
| +4% | +$3.48M | 0.03% | 560 |
|
|
2021
Q4 | $114M | Sell |
302,724
-11,693
| -4% | -$4.54M | 0.03% | 494 |
|
|
2021
Q3 | $130M | Buy |
314,417
+103,789
| +49% | +$43.1M | 0.04% | 457 |
|
|
2021
Q2 | $77.9M | Buy |
210,628
+110,590
| +111% | +$36.9M | 0.03% | 600 |
|
|
2021
Q1 | $29M | Buy |
100,038
+9,827
| +11% | +$2.73M | 0.01% | 786 |
|
|
2020
Q4 | $22.5M | Sell |
90,211
-2,597
| -3% | -$618K | 0.01% | 814 |
|
|
2020
Q3 | $21M | Buy |
92,808
+4,844
| +6% | +$1.01M | 0.01% | 776 |
|
|
2020
Q2 | $15.3M | Buy |
87,964
+8,472
| +11% | +$1.35M | 0.01% | 859 |
|
|
2020
Q1 | $10.1M | Buy |
79,492
+5,379
| +7% | +$807K | 0.01% | 902 |
|
|
2019
Q4 | $11.3M | Buy |
74,113
+5,262
| +8% | +$729K | 0.01% | 968 |
|
|
2019
Q3 | $9.11M | Buy |
68,851
+3,824
| +6% | +$513K | ﹤0.01% | 1018 |
|
|
2019
Q2 | $9.23M | Buy |
65,027
+212
| +0.3% | +$28.8K | 0.01% | 996 |
|
|
2019
Q1 | $9.41M | Buy |
64,815
+2,880
| +5% | +$378K | 0.01% | 910 |
|
|
2018
Q4 | $7.01M | Buy |
61,935
+1,872
| +3% | +$234K | 0.01% | 929 |
|
|
2018
Q3 | $8.08M | Sell |
60,063
-52
| -0.1% | -$6.42K | 0.01% | 946 |
|
|
2018
Q2 | $6.75M | Sell |
60,115
-1,043
| -2% | -$113K | 0.01% | 989 |
|
|
2018
Q1 | $6.53M | Buy |
61,158
+8,143
| +15% | +$878K | 0.01% | 975 |
|
|
2017
Q4 | $5.8M | Buy |
53,015
+6,896
| +15% | +$750K | ﹤0.01% | 1008 |
|
|
2017
Q3 | $4.98M | Buy |
46,119
+6,287
| +16% | +$646K | ﹤0.01% | 1027 |
|
|
2017
Q2 | $4.03M | Buy |
39,832
+8,254
| +26% | +$760K | ﹤0.01% | 1115 |
|
|
2017
Q1 | $2.84M | Buy |
31,578
+18,495
| +141% | +$1.57M | ﹤0.01% | 1260 |
|
|
2016
Q4 | $997K | Buy |
13,083
+6,883
| +111% | +$523K | ﹤0.01% | 1741 |
|
|
2016
Q3 | $517K | Buy |
6,200
+723
| +13% | +$60.6K | ﹤0.01% | 1675 |
|
|
2016
Q2 | $452K | Buy |
5,477
+213
| +4% | +$17.5K | ﹤0.01% | 1375 |
|
|
2016
Q1 | $400K | Buy |
5,264
+1,056
| +25% | +$78.2K | ﹤0.01% | 1414 |
|
|
2015
Q4 | $339K | Buy |
4,208
+507
| +14% | +$36.6K | ﹤0.01% | 1493 |
|
|
2015
Q3 | $235K | Buy |
3,701
+336
| +10% | +$24.1K | ﹤0.01% | 1630 |
|
|
2015
Q2 | $236K | Buy |
3,365
+1,841
| +121% | +$136K | ﹤0.01% | 1671 |
|
|
2015
Q1 | $121K | Sell |
1,524
-7,985
| -84% | -$589K | ﹤0.01% | 1912 |
|
|
2014
Q4 | $606K | Buy |
9,509
+71
| +0.8% | +$4.45K | ﹤0.01% | 1205 |
|
|
2014
Q3 | $564K | Hold |
9,438
| – | – | ﹤0.01% | 1177 |
|
|
2014
Q2 | $505K | Hold |
9,438
| – | – | ﹤0.01% | 1166 |
|
|
2014
Q1 | $569K | Hold |
9,438
| – | – | ﹤0.01% | 1106 |
|
|
2013
Q4 | $501K | Hold |
9,438
| – | – | ﹤0.01% | 1140 |
|
|
2013
Q3 | $437K | Hold |
9,438
| – | – | ﹤0.01% | 1145 |
|
|
2013
Q2 | $387K | Buy |
+9,438
| New | +$404K | ﹤0.01% | 1090 |
|
Other funds holding CRL
AI
Legal & General Group's CRL Position: Q2 2026 in Review
Legal & General Group increased its Charles River Laboratories (CRL) stake by 5.7% in Q2 2026, buying an estimated $984K and bringing the position to 102,433 shares worth $23.2M. The position accounts for ﹤0.01% of the portfolio, ranked #813.
Legal & General Group first reported a position in CRL in Q2 2013 and has held it in 53 quarters since. The position peaked at $130M in Q3 2021. 569 funds tracked by Wall St. Rank hold CRL as of Q2 2026.
- Legal & General Group held 102,433 shares of Charles River Laboratories worth $23.2M as of Q2 2026.
- Legal & General Group bought 5,523 Charles River Laboratories shares in Q2 2026, an estimated $984K.
- Charles River Laboratories made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #813 holding.
- Legal & General Group first reported a position in Charles River Laboratories in Q2 2013 and has held it in 53 quarters since.
- Legal & General Group's Charles River Laboratories position peaked at $130M in Q3 2021.
- 569 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.
Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.